Biomaterials Market

Biomaterials Market Size by Product (Natural, Metallic, Ceramics and Polymers), Applications (Ophthalmology, Dental, Cardiovascular, Would Healing, Orthopedic, Plastic Surgery, Neurology and Others), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13745
  • Published Date: Oct, 2023
  • Pages: 238
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global biomaterials market was valued at USD 162.54 Billion in 2022 and growing at a CAGR of 14.67% from 2023 to 2032. The market is expected to reach USD 638.96 Billion by 2032. Biomaterials have grown constantly for over half a century, using ideas from material science, engineering, medicine, biology and chemistry. The biomaterial market has grown due to factors such as a global surge in grants and funds by the government for novel materials, growing cases of cardiovascular disease and hence, the growing demand for medical implants. In orthopaedics, biomaterials are broadly used in spine fusion, fracture fixation and joint replacement. Implants made of biomaterials like ceramics, metals and polymers tend to easily meld with bone tissues Cardiovascular devices such as pacemakers and tubes are also made using biomaterials. Materials which are biocompatible and can withstand the stresses placed on the cardiovascular system are crucial to such a system. Similarly, in tissue engineering and regenerative medicines, biomaterials are crucial as they are used to build scaffolds that help new tissues such as bone, skin, and cartilage grow. Biomaterials are also used in delivering medication and other therapeutic agents to specific body parts.

Market Introduction:

Biomaterials are generally derived from nature or synthesized in the laboratory using several chemical methods using polymers, metallic elements, ceramics or composite materials. It is broadly used or modified for medical uses and thus comprises the whole or part of the biomedical devices which serve, improve or replace the natural function. The functionality can be comparatively passive, like in the heart valve, or bioactive, with many interactive features like hydroxy-apatite hip implants. Biomaterials are also broadly used in dental procedures, drug delivery and surgeries. For instance, the construction with impregnated pharmaceutical products is placed in the body, which helps in the prolonged release of drugs for long duration. The biomaterial market is growing due to the surge in funding and grants given by the government globally. Factors like the growing use of implantable devices, a growing number of hip and knee replacement surgeries, advancement in technology, more prevalence of cardiovascular diseases and a surge in the senior population are other factors driving the growth of the biomaterials market. Biomaterials are broadly used in the making of biomedical devices like the hydrogel contact lens, artificial heart valves, polymer or metal stents, knee and ligament implants, steel joint and hip replacements, ceramic dental implants, polymer vascular grafts, surgical adhesives, polymer sutures, porous dialysis membranes and polymer barrier films among others. The demand for medical products is growing due to a population surge and ageing; hence, preclinical and clinical biomaterial studies are also significantly growing. These synthetic or natural origin biomaterials are used to effectively treat many diseases like dental problems, tissue damage, bone cancer, orthopaedic injuries and cardiovascular disease, among others. The biomaterials considered safe, reliable and affordable for the abovementioned uses are metals, ceramics, polymers and those derived from natural origins.

Biomaterials Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • In February 2018: Carpenter Technology Corporation acquired MB CalRAM LLC. The acquisition brought CalRAM's leading technology and process, complementing Carpenter Technology's technical experience in producing highly engineered metal powders and powders used in additive manufacturing applications such as orthopaedic implants. It helps the organization gain market share in the biomaterial market. 
  • In August 2021: Evonik acquired JeNaCell, which is a German biotech organization. This acquisition helped the organization expand its biomaterials portfolio by offering biotechnologically derived cellulose, which helps in wound and burn care, among others. It is helping the organization gain market share in the biomaterial market.
  • In January 2023: Zimmer Biomet Holdings, Inc. has signed an agreement for the acquisition of Embody Inc., a medical device organization centred on soft tissue recovery. This acquisition will include a TAPESTRY bio-integrative implant for tendon recovery and TAPESTRY RC, among the first arthroscopic implant systems for rotator cuff restoration. It would eventually help the organization broaden its market share in the biomaterials market.

Market Dynamics:

Drivers

The growing cases of musculoskeletal medical conditionsThere is an increase in the cases of musculoskeletal and chronic skeletal medical conditions, which is boosting the demand for biomaterial-based implants, propelling the market's growth. The demand for orthopaedic implants is also growing due to a surge in the geriatric population and a growing risk of osteoporosis, osteoarthritis and other musculoskeletal conditions. There is also the development of several biomaterial and biomedical devices which are in demand as they help in detecting and treating coronavirus. There is also an introduction of smart biomaterials, which interact with the biological systems for many biomedical applications like the transportation of bioactive materials and cellular working of engineered functional tissues. All these factors are eventually propelling the growth of the biomaterials market.

Restraints:

Stringent government regulations– These biomaterial-based devices have to pass through several rules and regulations in regions like Asia Pacific, Europe and North America to ensure their effectiveness, as these devices are considered more insertable. Hence, all the new biomaterials are needed to confirm that they are secured and reasonable before they are put for showcasing. All these factors are eventually acting as a restraint to the market.

Opportunities:

The Surge in the geriatric population globally– Based on one of the studies in 2020, the population aged 60 and more outnumbered the children younger than 5 years. Similarly, between 2015 and 2050, the global population aged more than 60 will become almost double, i.e. from 12% to 22%. The pace of the ageing of the population has become faster than in the past. By 2030, 1 in 6 people in the world will be age 60 and more, and the aged population will grow from 1 billion in 2020 to around 1.4 Billion. By 2050, the global population aged 60 and more will double to around 2.1 Billion. The number of people aged 80 years and older is anticipated to be between 2020 and 2050 and will reach 426 million. All these populations will be more prone to severe medical conditions like cardiovascular and orthopaedic-related medical conditions. All these factors eventually propel the biomaterials market in the forecasting period.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global biomaterials market, with a 39.45% share of the market revenue in 2022. This market share is attributed to the surge in biomaterial-based research, growing cancer cases and an increase in the incidence of cardiovascular-related diseases. Also, there is a growing adoption of technologically advanced reconstruction devices, and there is an improvement in the healthcare infrastructure in the region, which is propelling the biomaterial market in the region. Moreover, there are many initiatives which private and public organizations undertake.

North America Region Biomaterials Market Share in 2022 - 39.45%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • Factors such as many key players in the market and favourable government policies are propelling the growth of the biomaterials market in the region.  
Product Segment Analysis

The product segment is divided into natural, metallic, ceramics and polymers. The polymers segment dominated the market, with a market share of around 30.13% in 2022. This significant share is because of several continuous research in developing biocompatible and biodegradable polymeric biomaterials and their usage in various applications. For instance, natural and synthetic polymers are broadly used in regenerative medicine and tissue engineering as they have diverse properties like degradability, bioactivity processing ability and mechanical properties.

Application Segment Analysis

The application segment is divided into ophthalmology, dental, cardiovascular, wound healing, orthopedic, plastic surgery, neurology and others. The orthopedic segment dominated the market, with a market share of around 22.43% in 2022. This significant share is attributed to several orthopaedic organizations finding ways to grow beyond the conventional orthopaedic implant market. Some of the biomaterials the leading orthopaedic device organizations used to boost their profits and growth are Allografts, polymer-based bone substitutes and viscosupplementation.

Some of the Key Market Players:
  • Medtronic plc
  • Carpenter Technology Corporation
  • Evonik Industries AG
  • Invibio Ltd.
  • Berkeley Advanced Biomaterials
  • BASF SE
  • Dentsply Sirona
  • Covalon Technologies Ltd.
  • Collagen Matrix, Inc.
  • Stryker
  • Johnson & Johnson
  • Zimmer Biomet Holdings, Inc.
  • CoorsTek Inc.
  • Corbion

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 162.54 Billion
Market size value in 2032 USD 638.96 Billion
CAGR (2023 to 2032) 14.67%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Product and Application

Frequesntly Asked Questions

North America region emerged as the largest market for the biomaterials.

The market's growth will be influenced by the growing cases of musculoskeletal medical conditions.

Stringent government regulations could hamper the market growth.

The surge in the geriatric population globally will provide huge opportunities to the market.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Product
          4.3.2. Market Attractiveness Analysis By Application
          4.3.3. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. The growing cases of musculoskeletal medical conditions
    5.3. Restraints
          5.3.1. Stringent government regulations
    5.4. Opportunities
          5.4.1. The Surge in the geriatric population globally
    5.5. Challenges
          5.5.1. Economic slowdown

6. Global Biomaterials Market Analysis and Forecast, By Product
    6.1. Segment Overview
    6.2. Natural
    6.3. Metallic
    6.4. Ceramics
    6.5. Polymers

7. Global Biomaterials Market Analysis and Forecast, By Application
    7.1. Segment Overview
    7.2. Ophthalmology
    7.3. Dental
    7.4. Cardiovascular
    7.5. Would Healing
    7.6. Orthopaedic
    7.7. Plastic Surgery
    7.8. Neurology
    7.9. Others

8. Global Biomaterials Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Biomaterials Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in Global Biomaterials Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. Medtronic plc
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Carpenter Technology Corporation
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. Evonik Industries AG
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Invibio Ltd.
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Berkeley Advanced Biomaterials
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. BASF SE
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Dentsply Sirona
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Covalon Technologies Ltd.
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Collagen Matrix, Inc.
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Stryker
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
    10.11. Johnson & Johnson
          10.11.1. Business Overview
          10.11.2. Company Snapshot
          10.11.3. Company Market Share Analysis
          10.11.4. Company Product Portfolio
          10.11.5. Recent Developments
          10.11.6. SWOT Analysis
    10.12. Zimmer Biomet Holdings, Inc.
          10.12.1. Business Overview
          10.12.2. Company Snapshot
          10.12.3. Company Market Share Analysis
          10.12.4. Company Product Portfolio
          10.12.5. Recent Developments
          10.12.6. SWOT Analysis
    10.13. CoorsTek Inc.
          10.13.1. Business Overview
          10.13.2. Company Snapshot
          10.13.3. Company Market Share Analysis
          10.13.4. Company Product Portfolio
          10.13.5. Recent Developments
          10.13.6. SWOT Analysis
    10.14. Corbion
          10.14.1. Business Overview
          10.14.2. Company Snapshot
          10.14.3. Company Market Share Analysis
          10.14.4. Company Product Portfolio
          10.14.5. Recent Developments
          10.14.6. SWOT Analysis
 

List of Table

1. Global Biomaterials Market, By Product, 2019-2032 (USD Billion)

2. Global Natural, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

3. Global Metallic, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

4. Global Ceramics, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

5. Global Polymers, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

6. Global Biomaterials Market, By Application, 2019-2032 (USD Billion) 

7. Global Ophthalmology, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

8. Global Dental, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

9. Global Cardiovascular, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

10. Global Would Healing, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

11. Global Orthopaedic, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

12. Global Plastic Surgery, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

13. Global Neurology, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

14. Global Others, Biomaterials Market, By Region, 2019-2032 (USD Billion) 

15. North America Biomaterials Market, By Product, 2019-2032 (USD Billion)

16. North America Biomaterials Market, By Application, 2019-2032 (USD Billion)

17. U.S. Biomaterials Market, By Product, 2019-2032 (USD Billion)

18. U.S. Biomaterials Market, By Application, 2019-2032 (USD Billion)

19. Canada Biomaterials Market, By Product, 2019-2032 (USD Billion)

20. Canada Biomaterials Market, By Application, 2019-2032 (USD Billion)

21. Mexico Biomaterials Market, By Product, 2019-2032 (USD Billion)

22. Mexico Biomaterials Market, By Application, 2019-2032 (USD Billion)

23. Europe Biomaterials Market, By Product, 2019-2032 (USD Billion)

24. Europe Biomaterials Market, By Application, 2019-2032 (USD Billion)

25. Germany Biomaterials Market, By Product, 2019-2032 (USD Billion)

26. Germany Biomaterials Market, By Application, 2019-2032 (USD Billion)

27. France Biomaterials Market, By Product, 2019-2032 (USD Billion)

28. France Biomaterials Market, By Application, 2019-2032 (USD Billion)

29. U.K. Biomaterials Market, By Product, 2019-2032 (USD Billion)

30. U.K. Biomaterials Market, By Application, 2019-2032 (USD Billion)

31. Italy Biomaterials Market, By Product, 2019-2032 (USD Billion)

32. Italy Biomaterials Market, By Application, 2019-2032 (USD Billion)

33. Spain Biomaterials Market, By Product, 2019-2032 (USD Billion)

34. Spain Biomaterials Market, By Application, 2019-2032 (USD Billion)

35. Asia Pacific Biomaterials Market, By Product, 2019-2032 (USD Billion)

36. Asia Pacific Biomaterials Market, By Application, 2019-2032 (USD Billion)

37. Japan Biomaterials Market, By Product, 2019-2032 (USD Billion)

38. Japan Biomaterials Market, By Application, 2019-2032 (USD Billion)

39. China Biomaterials Market, By Product, 2019-2032 (USD Billion)

40. China Biomaterials Market, By Application, 2019-2032 (USD Billion)

41. India Biomaterials Market, By Product, 2019-2032 (USD Billion)

42. India Biomaterials Market, By Application, 2019-2032 (USD Billion)

43. South America Biomaterials Market, By Product, 2019-2032 (USD Billion)

44. South America Biomaterials Market, By Application, 2019-2032 (USD Billion)

45. Brazil Biomaterials Market, By Product, 2019-2032 (USD Billion)

46. Brazil Biomaterials Market, By Application, 2019-2032 (USD Billion)

47. Middle East and Africa Biomaterials Market, By Product, 2019-2032 (USD Billion)

48. Middle East and Africa Biomaterials Market, By Application, 2019-2032 (USD Billion)

49. UAE Biomaterials Market, By Product, 2019-2032 (USD Billion)

50. UAE Biomaterials Market, By Application, 2019-2032 (USD Billion)

51. South Africa Biomaterials Market, By Product, 2019-2032 (USD Billion)

52. South Africa Biomaterials Market, By Application, 2019-2032 (USD Billion)

List of Figures 

1. Global Biomaterials Market Segmentation

2. Global Biomaterials Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Biomaterials Market Attractiveness Analysis By Product  

9. Global Biomaterials Market Attractiveness Analysis By Application 

10. Global Biomaterials Market Attractiveness Analysis By Region

11. Global Biomaterials Market: Dynamics

12. Global Biomaterials Market Share By Product (2023 & 2032)

13. Global Biomaterials Market Share By Application (2023 & 2032)

14. Global Biomaterials Market Share By Regions (2023 & 2032)

15. Global Biomaterials Market Share By Company (2022)

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global biomaterials market based on below mentioned segments:

Global Biomaterials Market by Product:

  • Natural
  • Metallic
  • Ceramics
  • Polymers

Global Biomaterials Market by Application:

  • Ophthalmology
  • Dental
  • Cardiovascular
  • Would Healing
  • Orthopedic
  • Plastic Surgery
  • Neurology
  • Others

Global Biomaterials by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date